0000899243-16-017727.txt : 20160406
0000899243-16-017727.hdr.sgml : 20160406
20160406170109
ACCESSION NUMBER: 0000899243-16-017727
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160405
FILED AS OF DATE: 20160406
DATE AS OF CHANGE: 20160406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
BUSINESS PHONE: 720-940-2200
MAIL ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ozeroff Christopher David
CENTRAL INDEX KEY: 0001454996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 161558119
MAIL ADDRESS:
STREET 1: 8001 ARISTA PLACE
STREET 2: SUITE 200
CITY: BROOMFIELD
STATE: CO
ZIP: 80021
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-04-05
0
0000907654
ARCA biopharma, Inc.
ABIO
0001454996
Ozeroff Christopher David
ARCA BIOPHARMA, INC.
11080 CIRCLEPOINT ROAD, SUITE 140
WESTMINSTER
CO
80020
0
1
0
0
S.V.P., General Counsel
Common Stock
2016-04-05
4
S
0
366
3.52
D
19585
D
Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person for satisfaction of their tax withholding obligation with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Equity Incentive Plan (the "Plan").
Includes (i) remaining 3,571 previously reported shares issued as RSUs under the Plan that vest on 9/17/16, (ii) remaining 2,443 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning on 2/27/17, and (iii) 2,290 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning 4/2/17, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 11,281 previously reported shares of common stock held directly.
/s/ Brian L. Selby, Attorney-in-Fact
2016-04-06